Epidemiology and outcome of severe hepatitis A infection in children in Kuwait

Medical Principles and Practice

Volumn 15, Issue 4, 2006, Pages 266-269

  Husain, Entesar ^a,b   Al Tawfiq, Jaffar A ^c   Husain, Khalid ^b  

^a Infectious Diseases Hospital Kuwait   (Kuwait)

^b AL AMIRI HOSPITAL   (Kuwait)

^c DHAHRAN HEALTH CENTER   (Saudi Arabia)

Author keywords

Hepatitis A vaccine; Hepatitis A virus; Kuwait

Indexed keywords

CLINICAL FEATURE; DISEASE SEVERITY; HEPATITIS A; HOSPITALIZATION; HUMAN; IMMUNIZATION; KUWAIT; MAJOR CLINICAL STUDY; MEDICAL RECORD; MORBIDITY; OUTCOME ASSESSMENT; PREVALENCE; REVIEW; SCHOOL CHILD; TIME SERIES ANALYSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS A; HUMANS; INFANT; INFANT, NEWBORN; KUWAIT; MALE; RETROSPECTIVE STUDIES; TRAVEL;

EID: 33745042491     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092988     Document Type: Review

References (15)

1. Alter MJ, Gallagher M, Morris TT, Moyer LA, Meeks EL, Krawczynski K, Kim JP, Margolis HS: Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. N Engl J Med 1997;336:741-746.
2. Craig AS, Schaffner W: Prevention of hepatitis A with the hepatitis A vaccine. N Engl J Med 2004;350:476-481.
3. Kemmer NM, Miskovsky EP: Infections of the liver; hepatitis A. Infect Dis Clin North Am 2000;14:605-615.
4. Ciccozzi M, Tosti ME, Gallo G, Ragni P, Zotti C, Lopalco P, Ara G, Sangalli M, Balocchini E, Szklo AS, Mele A, SEIEVA collaborating group: Risk of hepatitis A infection following travel. J Viral Hepat 2002;9:460-465.
5. Tufenkeji H: Hepatitis A shifting epidemiology in the Middle East and Africa. Vaccine 2000;18:S65-S67.
6. Ministry of Health, Kuwait. Vital Statistics Book, 2002.
7. Fathalla SE, Al-Jama AA, Al-Sheikh IH, Islam SI: Seroprevalence of hepatitis A virus in Eastem Saudi Arabia. Saudi Med J 2000;21:945-948.
8. Nordenfelt E, Atack W, Al-Kandari, Al-Nakib W: Hepatitis A in Kuwait. J Kuwait Med Assoc 1985;19:103-108.
9. Kang JH, Lee KY, Kim CH, Sim D: Changing hepatitis A epidemiology and the need for vaccination in Korea. Asian Pac J Allergy Immunol 2004;22:237-242.
10. Staes CJ, Schlenker TL, Risk I, Cannon KG, Harris H, Pavia AT, Shapiro CN, Bell BP: Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics 2000;106:E54.
11. Bell BP, Shapiro CN, Alter MJ, Moyer LA, Judson FN, Mottram K, Fleenor M, Ryder PL, Margolis HS: The diverse patterns of hepatitis A epidemiology in the United States: implications for vaccination strategies. J Infect Dis 1998;178:1579-1584.
12. Meyerhoff AS, Jacobs RJ: Transmission of hepatitis A through household contact. J Viral Hepat 2001;8:454-458.
13. Weinberg M, Waterman S, Lucas CA, Falcon VC, Morales PK, Lopez LA, Peter C, Gutierrez AE, Gonzalez ER, Flisser A, Bryan R, Valle EN, Rodriguez A, Hernandez GA, Rosales C, Ortiz JA, Landen M, Vilchis H, Rawlings J, Leal FL, Ortega L, Flagg E, Conyer RT, Cetron M: The US-Mexico Border Infectious Disease Surveillance project: establishing bi-national border surveillance. Emerg Infect Dis 2003;9:97-102.
14. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999;48:1-37.
15. Wiedermann G, Kundi M, Ambrosch F: Estimated persistence of anti-HAV antibodies after single dose and booster hepatitis A vaccination (0-6 schedule). Acta Trop 1998;69:121-125.